TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
IMNM

Immunome Inc

Healthcare · Biotechnology

19.10$ -1.1% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow IMNM
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– +18.0% +22.8% +0.0% -16.4% +15.4% +188.7% +40.6%
– +27.3% +4,335.7% +455.2% +54.6% +16.7% +153.1% +63.1%
– -15.0% +36,117.6% -52.1% +80.6% – – –
– – -670.3% – -19.3% +434.9% +24.0% -202.4%
– +2.2% +151.5% -86.5% +213.9% +235.1% +6,339.0% -81.9%
– +2.2% +151.5% -86.5% +213.9% +12,191.9% +179.0% –
– – -98.9% – – – – –
– – +40.0% – – – – –
– +11.1% – -330.6% – – – –
– – +363.6% -44.4% -99.9% +363,675.0% +106.6% +166.2%
– – +3,855.7% -74.6% -405.5% – -43.0% +1,042.2%
– – – – – – – –

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?